Search Results
Case 1: Patient with high-risk smoldering myeloma
Smoldering myeloma: Who and when to treat?
Daratumumab for Patient with High-risk Smoldering Myeloma | Rahul Banerjee | #ASH24
What Causes Smoldering Myeloma and Who is at High Risk?
Better understanding smoldering myeloma & improving the outcomes of patients with high-risk myeloma
Dr. Landgren on the Treatment of High-Risk Smoldering Myeloma
Diagnosis and Risk Stratification of Plasma Cell Disorders (pt 1 of 5 - IMF ASH Satellite)
Treatments Available for High Risk Smoldering Myeloma Patients
How do the two approaches to treating high-risk smoldering multiple myeloma (HRSMM) patients differ?
Case 1: 51-Year-Old Man With Standard-Risk Myeloma
High Risk and Smoldering Multiple Myeloma
Smoldering Multiple Myeloma – Defining High Risk and Deciding Who to Treat
